<![CDATA[Sustainable GLP-1 Coverage Requires Balancing Access, Cost, and Long-Term Value]]>

How many Canadian employers are offering GLP-1 coverage for weight loss?

Cost control, eligibility requirements, and health risks of obesity among key factors shaping employer approach to medication: IFEBP survey

Medicare begins covering weight-loss medications: who qualifies and how the new program will work

A pilot program will, for the first time, allow millions of beneficiaries to access GLP-1 medications to treat obesity with a monthly copay

Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn

Stronger safeguards are needed to ensure independent and transparent recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists and r

Medicare Will Soon Offer Low-Cost GLP-1 Weight-Loss Drugs. What You Need to Know

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

Stronger safeguards are needed to ensure independent and transparent recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists and r

CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications

CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications Eligible Medicare beneficiaries may now get certain GLP-1 medicati